- Home
- PODD vs IBKR Comparison
PODD vs IBKR Comparison
Compare PODD & IBKR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PODD
- IBKR
- Stock Information
- Founded
- PODD 2000
- IBKR 1977
- Country
- PODD United States
- IBKR United States
- Employees
- PODD N/A
- IBKR N/A
- Industry
- PODD Medical/Dental Instruments
- IBKR Investment Bankers/Brokers/Service
- Sector
- PODD Health Care
- IBKR Finance
- Exchange
- PODD Nasdaq
- IBKR Nasdaq
- Market Cap
- PODD 16.5B
- IBKR 18.7B
- IPO Year
- PODD 2007
- IBKR 2007
- Fundamental
- Price
- PODD $260.12
- IBKR $180.21
- Analyst Decision
- PODD Buy
- IBKR Strong Buy
- Analyst Count
- PODD 15
- IBKR 8
- Target Price
- PODD $251.53
- IBKR $144.00
- AVG Volume (30 Days)
- PODD 609.1K
- IBKR 936.0K
- Earning Date
- PODD 11-07-2024
- IBKR 10-15-2024
- Dividend Yield
- PODD N/A
- IBKR 0.55%
- EPS Growth
- PODD 235.68
- IBKR 16.74
- EPS
- PODD 5.74
- IBKR 6.42
- Revenue
- PODD $1,983,900,000.00
- IBKR $4,943,000,000.00
- Revenue This Year
- PODD $22.33
- IBKR $17.69
- Revenue Next Year
- PODD $18.50
- IBKR $1.44
- P/E Ratio
- PODD $45.35
- IBKR $28.07
- Revenue Growth
- PODD 27.42
- IBKR 16.66
- 52 Week Low
- PODD $160.19
- IBKR $72.60
- 52 Week High
- PODD $279.40
- IBKR $181.21
- Technical
- Relative Strength Index (RSI)
- PODD 63.27
- IBKR 77.85
- Support Level
- PODD $233.48
- IBKR $176.50
- Resistance Level
- PODD $276.57
- IBKR $181.21
- Average True Range (ATR)
- PODD 8.53
- IBKR 3.91
- MACD
- PODD 2.16
- IBKR 1.82
- Stochastic Oscillator
- PODD 63.19
- IBKR 96.68
About PODD Insulet Corporation
Insulet was founded in 2000 with the goal of making continuous subcutaneous insulin infusion therapy for diabetes easier to use. The result was the Omnipod system, which consists of a small disposable insulin infusion device and that can be operated through a smartphone to control dosage. Since the Omnipod was approved by the U.S. Food and Drug Administration in 2005, approximately 425,000 insulin-dependent diabetics are using it worldwide.
About IBKR Interactive Brokers Group Inc.
Interactive Brokers is an online brokerage that generates trading commissions (around 31% of net revenue) from facilitating trading in a wide range of products, including equity, options, futures, foreign exchange, bonds, mutual funds, and ETFs. Interactive Brokers also generates net interest income (about 64% of net revenue) from idle client cash and earns fees (about 6% of net revenue) from ancillary services. Principal trading and other miscellaneous activities are small (about 5% of net revenue). The firm derives about 70% of its net revenue from the U.S. and 30% from international markets.